News and Comments

INCYTE: SHOWS ITS PATH TOWARDS GROWTH

  Wednesday, February 12, 2014

 More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Ridaforolimus Rapamune Cytokinetics (CYTK) Intercept (ICPT) CompuGen (CGEN) OSI (OSIP) Zerenex GUARDIAN HEALTH Dendreon (DNDN) Ionis (IONS) Agenus (AGEN) AERIE PHARMACEUTICALS KITE (KITE) Inovio (INO) Exelixis (EXEL) JUNO (JUNO) Jazz Pharmaceuticals (JAZZ) Biocryst (BCRX) ADVENTRIX (ANX) IDERA (IDRA) Illumina (ILMN) Multiple Myeloma Intermune (ITMN) Sanofi (SNA) Prolor Biotech (PBTH) NANTKWEST (NK) Alder Biopharmaceuticals (ALDR) Vertex (VRTX) SYNTA (SNTA) GlaxoSmithKline (GSK) ABBVIE (ABBV) Pluristem (PSTI) galapagos (GLPG) Bristol-Myers Squibb (BMY) Amgen (AMGN) Endometrial Cancer BIOMARIN (BMRN) Human Genome Sciences (HGSI) Auspex (ASPX) Velcade (bortezomib) Vitae Pharmaceuticals (VTAE) Ziofpharm (ZIOP) TOKAI (TKAOI) Agenus (AGEN Intrexon (XON) Ariad (ARIA) Valeant Pharmaceuticals International (VRX) Sangamo (SGMO) Array Pharmaceuticals (ARRY) Anadys (ANDS) Seattle Genetics (SGEN) Gilead (GILD) Human Longevity (HLI) Alnylam (ALNY) Trastuzumab-DM1 Theravance (THRX) Revlimid (lenolidamide) Aimmune Therapeutics (AIMT) HALOZYME (HALO) Genentech Abbott Laboratories (ABT) Sequenom (SQNM) Xoma (XOMA) SUNESIS PHARMACEUTICALS (SNSS) Dynavax (DVAX) Onyx (ONXX) ZALTRAP™ Prosensa (RNA) Tysabri Regeneron (REGN) C4 Therapeutics ACADIA (ACAD) Roche (RHHBY) Theravance Bio Pharma (TBPH) Idenix (IDIX) Merck (MRK) SERES THERAPEUTICS (MCRB) VANDA (VNDA) ARCA (ABIO) Micromet (MITI) KERYX (KERX) Benlysta (belimumab) Elan (ELN) ImmunoGen (IMGN) Sanofi (SNY) Anacor (ANAC) REGULUS (RGLS) Biogen Idec (BIIB) Sarepta (SRPT) Mirati Therapeutics (MRTX) Herceptin Galena (GALE) Sanofi-Aventis (SAN) NEKTAR (NKTR)) Telaprevir Roche (ROCHE) ISIS (ISIS) Incyte (INCY)